FDA Authorizes New Over-the-Counter Naloxone Product

The U.S. Food and Drug Administration has granted approval for Rextovy, an additional naloxone nasal spray, to be sold without a prescription. This new product will be available in retail locations like convenience stores, expanding access to emergency treatment for opioid overdoses. This move aims to enhance public health efforts in combating the opioid crisis.